Form 13-F position report

RA MED SYS INC

Reported by HARBOUR INVESTMENTS INC

RMED CUSIP 74933X203 Manager CIK 0000810121

Reported 1,000 shares, unchanged from the prior quarter.

Reported value -100.0%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 0 This manager · Q2 2022
Shares 1,000 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 1 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 2000
2022-06-30 0
2022-09-30 0
2022-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

4 quarters
Quarterly reported position history for RA MED SYS INC held by HARBOUR INVESTMENTS INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2022 Reduced 0 -1,000 (-100.0%) 0 $0 2023-02-16
Q3 2022 Unchanged 1,000 0 (0.0%) 0 $0 2022-11-15
Q2 2022 Unchanged 1,000 0 (0.0%) 0 $0 2022-08-15
Q4 2021 New 1,000 +1,000 (0.0%) < 0.01% $2,000 2022-02-16

Who else reported the position

28 managers reported RA MED SYS INC for Q2 2022.

Managers reporting RA MED SYS INC in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Reduced 333,762 -4,733 < 0.01% $105,000 6 qtrs
Avantax Planning Partners Inc Added 78,000 +60,000 < 0.01% $24,000 4 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 73,247 +31,450 < 0.01% $23,000 6 qtrs
Virtu Financial LLC Reduced 63,569 -130,108 < 0.01% $20,000 6 qtrs
UBS Group AG Reduced 36,820 -31,189 < 0.01% $12,000 4 qtrs
BOURNE LENT ASSET MANAGEMENT INC Unchanged 36,848 0 < 0.01% $12,000 2 qtrs
Tower Research Capital LLC TRC New 21,702 +21,702 < 0.01% $7,000 4 qtrs
HighTower Advisors LLC Unchanged 19,794 0 < 0.01% $6,000 2 qtrs
StoneX Group Inc New 14,000 +14,000 < 0.01% $4,397 1 qtr
STATE STREET CORPORATION Added 12,310 +2,010 < 0.01% $4,000 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 15, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
0
Shared
0
None
1,000

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.